Ro Patrick and Dr. Jose Prince talk about the responsibility and unique role HCPs play in helping to prevent gun violence. Sudden cardiac death increases amid lower daily temperatures. Acoramidis therapy significantly increases serum transthyretin in people with ATTR-CM compared with tafamidis. Patients with single ventricle heart disease commonly have mental health diagnoses. Acoramidis therapy induces a significant increase in serum transthyretin, which is typically lower in ATTRv-CM. The U.S. FDA approved Tremfya for the treatment of adults with moderately to severely active Crohn disease. Dr. Anne Marie Morse elucidates how DST affects our sleep cycles and why our bodies may feel different while adjusting. A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO. Mothers who follow a Western diet during pregnancy may have an increased risk of having children with ADHD, or autism. Food insecurity is linked with an increased risk of developing heart disease. People with CD who have associated joint inflammation due to immune system dysfunction carry distinct gut bacteria. Dr. Anne Marie Morse, about the significance and theme of this year’s World Sleep Day. Patients between the ages of 50 and 70 years with a mechanical heart valve have better long-term survival. Understanding the signs and symptoms of hantavirus, the infection the claimed the life of Gene Hackman's wife. Dr. Amin Mirhadi details the benefits and disadvantages of using proton therapy in patients with head and neck cancer. Dr. Mithu Maheswaranathan talks about the findings of a study which assessed obinutuzumab for patients with active lupus. A novel imaging technique added to MRI allows clinicians to better tailor rehabilitation for stroke patients. The global burden of cervical cancer, as well as cervical cancer mortality, is predicted to increase substantially by 2030. Finerenone therapy may prevent worsening heart failure in outpatients with mildly reduced or preserved ejection fraction. Cancer recurrence fear appreciably impacts breast cancer survivors’ ability to re-enter the workforce.